Skip to main content
Nutrition & Diabetes logoLink to Nutrition & Diabetes
. 2021 Sep 14;11:28. doi: 10.1038/s41387-021-00172-1

Paternal weight prior to conception and infant birthweight: a prospective cohort study

Ravi Retnakaran 1,2,3,, Shi Wu Wen 4,5,6,7, Hongzhuan Tan 7, Shujin Zhou 8, Chang Ye 1, Minxue Shen 4,5,6,7, Graeme N Smith 9, Mark C Walker 4,5,6
PMCID: PMC8440552  PMID: 34521807

Abstract

Background/Objective

Previous studies have consistently demonstrated that maternal weight status both before and during pregnancy is associated with infant birthweight. However, a fundamental limitation across this literature remains that previous studies have not evaluated the concomitant impact of paternal weight at conception, owing to the paucity of studies in which fathers were assessed prior to pregnancy. Thus, we established a cohort of preconception couples to prospectively evaluate the associations of maternal and paternal weight prior to pregnancy with infant birthweight at delivery.

Methods

In this prospective observational cohort study, 1292 newly-married women and their partners in Liuyang, China, were assessed at median of 23.3 weeks before a singleton pregnancy, thereby enabling concomitant assessment of preconception maternal and paternal body mass index (BMI) in relation to infant birthweight.

Results

Mean birthweight was 3294 ± 450 g with 147 neonates (11.4%) born large-for-gestational-age (LGA) and 94 (7.3%) small-for-gestational-age (SGA). After adjustment for maternal and paternal factors prior to conception (age, education, smoking, BMI, household income), length of gestation, total gestational weight gain, gestational diabetes, preeclampsia, and infant sex, it was noted that infant birthweight increased by 42.2 g (95% CI 29.5–54.8; p < 0.0001) per unit increase in maternal pregravid BMI and 10.7 g (95% CI 0.5–20.9; p = 0.04) per unit increase in paternal pregravid BMI. Maternal pregravid BMI explained 6.2% of the variance in birthweight whereas paternal BMI explained only 0.7%. Independent predictors of LGA delivery were maternal pregravid BMI (aOR = 1.91, 95% CI 1.50–2.44), maternal age (aOR = 1.48, 95% CI 1.09–2.00), and gestational weight gain (aOR = 1.80, 95% CI 1.40–2.30). Paternal pregravid BMI was not independently associated with LGA or SGA.

Conclusion

Paternal BMI prior to conception is associated with infant birthweight but only modestly so, in contrast to the dominant impact of maternal weight.

Subject terms: Risk factors, Epidemiology

Introduction

Infant birthweight is a neonatal outcome that holds both short- and long-term implications. In the short-term, at delivery, macrosomia is associated with increased risks of shoulder dystocia, birth injury, and the need for Cesarean section [1]. Over the long-term, individuals born with low birthweight (and to a lesser degree those with high birthweight) have elevated risks of developing type 2 diabetes and coronary artery disease several decades later in adulthood [2, 3]. The presumed mechanistic basis underlying these long-term associations is the Developmental Origins of Health and Disease (DOHaD) paradigm, which posits that intrauterine exposures program developmental pathways in the fetus that affect both birthweight and later-life trajectories of cardiometabolic risk [2]. Accordingly, given these implications, investigation of the determinants of birthweight is a well-established focus of research interest.

In this context, previous studies have consistently identified maternal weight status both at conception and during pregnancy as a key determinant of infant birthweight [46]. However, a fundamental limitation across this literature remains that previous studies have not evaluated the concomitant impact of paternal weight at conception [710]. Though paternal weight at conception is recognized as a factor of great interest, its evaluation in previous studies has been precluded by the logistical challenge of identifying, recruiting, and assessing couples just prior to pregnancy. Thus, to address this critical knowledge gap, we have established a cohort of preconception couples to prospectively evaluate the associations of pregravid maternal and paternal weight with infant birthweight.

Methods

For this study, we constructed a prospective preconception observational cohort, in which couples in the Liuyang region of Hunan province in China were recruited at the time of marriage. In this cohort, participating women and their partners underwent baseline (pregravid) evaluation at recruitment and then, whenever they subsequently became pregnant, were followed across gestation to delivery [11, 12]. The study was approved by the institutional research ethics boards of Central South University (Changsha, Hunan, China), Ottawa Hospital Research Institute (Ottawa, Canada), and Mount Sinai Hospital (Toronto, Canada), and all participants provided written informed consent.

Construction of preconception cohort

To establish a preconception cohort in a cost-efficient manner, it is necessary to have a way of identifying women who are likely to become pregnant in the near future. This opportunity exists in Liuyang because women in this region attend a premarriage health clinic for assessment at the time of marriage registration. Thus, to establish this cohort, we recruited women from these clinics at Liuyang Maternal and Infant Hospital, if they indicated an intention to conceive in the next 6 months. The partners of participating women were also approached for participation. Beginning in February 2009, 3375 women were recruited into a maternal cohort, of whom 2382 have completed a singleton pregnancy. Amongst these women, 1519 male partners underwent baseline pregravid evaluation. After the exclusion of 40 women who were >5 weeks pregnant at their baseline assessment based on back-dating of gestational age at delivery and 187 women with incomplete infant delivery data, the study population for the current analysis consisted of 1292 couples who completed their baseline visit prior to a singleton pregnancy (Online Fig. 1). At the baseline visit, both parents completed interviewer-administered questionnaires and underwent physical examination included assessment of blood pressure and anthropometry (weight, height, and waist circumference) by trained study staff. Blood pressure was measured in a seated position, after 10 min of rest, using an automated noninvasive blood pressure monitor, with two measurements performed 10 min apart and the average recorded. Height and weight were measured with a wall-mounted stadiometer and scale, with both measurements performed twice and the average recorded for each. Waist circumference was measured at the midpoint between the lower edge of the ribs and the iliac crest, with two measurements performed and the average recorded.

Assessment at delivery

Data collected at delivery included gestational age (based on last menstrual period), total weight gain in pregnancy (weight was measured at each clinical visit in pregnancy and prior to delivery), major maternal medical complications in pregnancy (including gestational diabetes mellitus and preeclampsia), infant sex, birthweight, and mode of delivery. At the participating hospital, all pregnant women undergo a 2-h 75 g oral glucose tolerance test as screening for gestational diabetes. Gestational diabetes was diagnosed on the oral glucose tolerance test if one of the following thresholds were met: fasting glucose ≥5.1 mmol/l; 1-h glucose ≥10.0 mmol/l; or 2-h glucose ≥8.5 mmol/l. Preeclampsia was diagnosed based on blood pressure ≥140/90 mmHg and 24-h urine protein >0.3 g or positive random urine protein, at ≥20 weeks gestation. Large-for-gestational-age (LGA) was defined as birthweight for gestational age above the 90th percentile according to birthweight centiles for a Chinese population [13]. Small-for-gestational-age (SGA) was defined as birthweight for gestational age below the tenth percentile on birthweight centiles for a Chinese population [13].

Statistical analyses

All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). Continuous variables were tested for normality of distribution, with natural log-transformation applied where necessary for skewed variables. The study population was first stratified into tertiles based on infant birthweight, enabling the comparison of maternal and paternal characteristics between these groups (Table 1). Continuous variables were compared using analysis of variance for those that were normally distributed and Wilcoxon rank-sum nonparametric test for those that were skewed. Categorical variables were compared by chi-square or Fisher’s exact test.

Table 1.

Characteristics of study population before pregnancy and at delivery, stratified by tertile of infant birthweight. Continuous data are presented as mean ± SD (if normally distributed) or median followed by interquartile range in parentheses (if skewed).

Lowest tertile Middle tertile Highest tertile
[1250–3060 g] [3100–3450 g] [3500–6000 g]
Pregravid characteristics n = 372 n = 478 n = 442 P
Age:
Maternal (yrs) 24 ± 3 25 ± 3 25 ± 3 0.01
Paternal (yrs) 26 ± 3 26 ± 3 26 ± 4 0.06
Years of education:
Maternal (yrs) 9 (9–12) 11 (9–12) 12 (9–12) 0.08
Paternal (yrs) 9 (9–12) 9 (9–12) 9 (9–12) 0.17
Household income (1000 yuan) 20 (10–30) 20 (19–30) 20 (12–30) 0.004
Smoking:
Maternal (n (%)) 0 (0) 1 (0.2) 5 (1.2) 0.03
Paternal (n (%)) 180 (51.3) 195 (45.1) 178 (43.6) 0.09
BMI:
Maternal (kg/m2) 19.7 ± 2.3 20.1 ± 2.4 20.6 ± 2.6 <0.0001
Paternal (kg/m2) 21.6 ± 2.6 22.3 ± 2.7 22.0 ± 2.6 0.0008
Waist:
Maternal (cm) 68.8 ± 7.7 70.7 ± 7.6 72.0 ± 7.3 <0.0001
Paternal (cm) 74.5 ± 8.1 75.7 ± 8.0 75.9 ± 8.1 0.02
At delivery
Length of gestation (weeks) 38 ± 2 39 ± 1 39 ± 1 <0.0001
Total gestational weight gain (kg) 15.0 ± 6.1 16.7 ± 6.5 18.8 ± 7.0 <0.0001
Gestational diabetes (n (%)) 5 (1.3) 7 (1.5) 14 (3.2) 0.10
Preeclampsia (n (%)) 11 (3.0) 4 (0.8) 4 (0.9) 0.03
Cesarean delivery (n (%) 124 (33.7) 148 (31.2) 201 (45.9) <0.0001
Male infant (n (%)) 167 (44.9) 240 (50.2) 266 (60.2) <0.0001
Birthweight (g) 2782 ± 267 3262 ± 112 3759 ± 286 <0.0001
LGA (n (%)) 1 (0.3) 0 (0) 146 (33.0) <0.0001
SGA (n (%)) 94 (25.3) 0 (0) 0 (0) <0.0001

Multiple linear regression analysis was conducted to identify independent determinants of infant birthweight (Table 2). Covariates in this model included maternal and paternal factors prior to conception (age, years of education, smoking status, BMI, and household income), and antepartum factors that are known or expected to influence birthweight (length of gestation, total gestational weight gain, gestational diabetes, preeclampsia, and infant sex). Since the study population consisted of newly-married couples wherein paternal BMI and maternal BMI were not strongly associated (Spearman correlation coefficient r = 0.05, p = 0.087), we included both paternal and maternal BMI in the model. A simple linear regression of each covariate was also conducted in parallel to determine the unadjusted association with infant birthweight. Furthermore, to explain the comparative associations of maternal and paternal BMI before conception on subsequent infant birthweight, we used partial R2 to measure the contribution of maternal and paternal BMI to the variance of infant birthweight, when controlling other covariates.

Table 2.

Change in infant birthweight in relation to pregravid and pregnancy factors. Data were presented as the change in birthweight per unit change in the indicated variable, either unadjusted (crude) or after adjustment for all of the other listed variables.

Change in infant birthweight (g)
Variables Crude (95% CI) Adjusted (95% CI)* P**
Maternal age (yrs) 14.8 (6.8 to 22.8) 20.3 (8.2 to 32.5) 0.001
Paternal age (yrs) 7.0 (−0.2 to 14.3) −2.2 (−13.6 to 9.3) 0.71
Maternal education (yrs) 11.2 (1.0 to 21.5) 5.6 (−9.8 to 20.9) 0.47
Paternal education (yrs) 6.8 (−3.2 to 16.8) 6.4 (−7.8 to 20.6) 0.38
Household income (1000 yuan) 2.5 (1.0 to 4.0) 0.7 (−1.4 to 2.8) 0.52
Maternal smoking 516.5 (157.2 to 875.8) 138.3 (−413.0 to 689.6) 0.62
Paternal smoking −43.6 (−95.6 to 8.4) −20.4 (−80.1 to 39.4) 0.50
Maternal pregravid BMI (kg/m2) 28.9 (18.0 to 39.8) 42.2 (29.5 to 54.8) <0.0001
Paternal pregravid BMI (kg/m2) 11.3 (2.1 to 20.5) 10.7 (0.5 to 20.9) 0.04
Length of gestation (weeks) 142.3 (125.7 to 158.8) 137.2 (115.0 to 159.3) <0.0001
Total gestational weight gain (kg) 16.1 (12.1 to 20.2) 18.0 (13.5 to 22.4) <0.0001
Gestational diabetes 251.9 (77.2 to 426.5) 92.1 (−127.2 to 311.4) 0.40
Preeclampsia −338.4 (−541.9 to −135.0) −236.0 (−479.0 to 7.0) 0.06
Male infant 133.6 (84.9 to 1852.3) 174.0 (114.7 to 233.3) <0.0001

*Adjusted for all other variables listed. The adjusted estimates can be interpreted in the following way: Infant birthweight increased by 137.2 g per additional week of gestation, after adjustment all of the other variables.

**P value refers to estimate for indicated variable in the adjusted model.

Multiple logistic regression analysis was conducted to identify independent determinants of LGA (Fig. 1A). This model included the same covariates as the multiple linear regression of birthweight, with the exception of the length of gestation and infant sex (both of which are incorporated into the definition of LGA). A simple logistic regression was also applied to each covariate to examine its unadjusted association with LGA. The same approach was applied to logistic regression analysis of SGA, with the same covariates as those for the LGA model (Fig. 1B).

Fig. 1. Predictors of large-for-gestational age and small-for-gestational age.

Fig. 1

Pregravid and antepartum predictors of (A) delivering a large-for-gestational-age (LGA) infant and (B) delivering a small-for-gestational-age (SGA) infant. Data were presented as odds ratio per standard deviation change in the indicated variable, either unadjusted or after adjustment for all of the other listed variables.

Results

The study population consisted of 1292 newly-married women and their partners, who were assessed at median of 23.3 weeks before a singleton pregnancy. At delivery, the mean infant birthweight was 3294 ± 450 g, with 147 neonates (11.4%) born LGA and 94 (7.3%) SGA. Table 1 shows the characteristics of the study population, stratified into three groups based on tertiles of infant birthweight. At the pregravid assessment, maternal BMI and paternal BMI both increased progressively across the groups from the lowest to the middle to highest tertile of infant birthweight (p < 0.0001 and p = 0.0008, respectively). The same pattern was observed for maternal and paternal waist circumference (p < 0.0001 and p = 0.02, respectively), maternal age (p = 0.01), and household income (p = 0.004). At delivery, the prevalence of male infant and Cesarean delivery increased from the lowest to the highest tertile of birthweight (both p < 0.0001), coupled with longer length of gestation and greater gestational weight gain (both p < 0.0001). In addition, the prevalence of preeclampsia was highest in the lowest tertile of birthweight (p = 0.03).

We next performed multiple linear regression analysis to identify independent determinants of infant birthweight (Table 2). In a model that explained 33.2% of the variance in birthweight, both maternal pregravid BMI and paternal pregravid BMI emerged as significant predictors of this outcome (p < 0.0001 and p = 0.04, respectively). Other significant predictors of birthweight were total gestational weight gain (p < 0.0001), length of gestation (p < 0.0001), male infant (p < 0.0001), and maternal age (p = 0.001). Paternal age was not significantly associated with birthweight.

We next performed a series of sensitivity analyses. First, when we excluded the 52 infants with a length of gestation <37 weeks, the significant predictors of birthweight were unchanged, including maternal pregravid BMI (p < 0.0001), paternal pregravid BMI (p = 0.03), total gestational weight gain (p < 0.0001), length of gestation (p < 0.0001), male infant (p < 0.0001), and maternal age (p = 0.0006) (data not shown). Second, when the model included paternal pregravid weight and height in place of BMI, paternal weight (p = 0.04), but not height (p = 0.43), was associated with infant birthweight, while the other significant predictors were unchanged (data not shown). Third, a sensitivity analysis in which pregravid maternal and paternal BMI were replaced with the analogous pregravid parental waist circumference measurements yielded similar findings to those in Table 2 except that only maternal but not paternal waist was associated with birthweight (p < 0.0001 and p = 0.15, respectively) (data not shown). Finally, when the multiple linear regression analysis was limited to the 506 pregnancies in which either the father or the mother had pregravid overweight (defined by BMI ≥23 kg/m2), the findings were again similar, with only maternal BMI (p < 0.0001) but not paternal BMI (p = 0.13) associated with birthweight (data not shown).

To further elucidate the comparative associations of maternal and paternal BMI before conception on subsequent infant birthweight, we returned to the multiple linear regression model in Table 2. When this model did not include paternal BMI, maternal pregravid BMI explained 6.2% of the variance in birthweight. Upon the addition of paternal BMI to the model, the proportion of the variance explained by maternal pregravid BMI was unchanged (6.2%), while paternal BMI reconciled only 0.7%. Thus, while paternal pregravid BMI is significantly associated with infant birthweight, its impact is modest, as compared to that of maternal prepregnancy weight.

On logistic regression analysis, the significant predictors of having an LGA infant were maternal pregravid BMI (aOR = 1.91, 95% CI 1.50–2.40), maternal age (aOR = 1.48, 95% CI 1.09–2.00), and total gestational weight gain (aOR = 1.80, 95% CI 1.40–2.30) (Fig. 1A). Neither paternal BMI nor paternal age prior to conception was significantly associated with LGA. These findings were unchanged when pregravid maternal and paternal BMI were replaced with the analogous pregravid parental waist circumference measurements (data not shown). The only significant predictors of having an SGA infant were total gestational weight gain (aOR = 0.63, 95% CI 0.46–0.85) and preeclampsia (aOR = 10.89, 95% CI 2.7–43.5) (Fig. 1B). Neither maternal nor paternal BMI prior to conception was associated with SGA.

Discussion

In this study, infant birthweight increased by 42.2 g per unit increase in maternal pregravid BMI but by only a 10.7 g per unit increase in paternal pregravid BMI. Indeed, maternal pregravid BMI explained 6.2% of the variance in birthweight whereas paternal BMI explained only 0.7%. Moreover, maternal BMI before pregnancy (but not paternal) was a significant independent predictor of LGA. It thus emerges that paternal BMI prior to conception is modestly associated with infant birthweight, in contrast to the dominant impact of maternal pregravid weight.

While previous studies have consistently demonstrated that maternal weight before pregnancy is associated with infant birthweight [4, 5], it is important to recognize that the estimated association is typically biased by two factors. First, most studies do not have a direct measurement of maternal pregravid weight. Instead, because these studies typically recruit women during pregnancy, they either treat a first trimester weight measurement as a surrogate for pregravid weight or rely upon maternal self-report [14]. Second, previous reports have not accounted for the potential impact of paternal weight prior to conception [710]. Though some studies have measured paternal weight during pregnancy or at delivery [15, 16], the optimal design for addressing both of the limitations is a direct measurement of maternal and paternal anthropometry prior to conception, as in the current study.

The potential importance of considering maternal and paternal weight at the time of conception has been underscored by recognition of the DOHaD paradigm and, most recently, the emergence of the related concept of the Paternal Origins of Health and Disease (POHaD) [10, 17]. The POHaD concept holds that paternal factors (such as adiposity) can affect male germ cells, leading to their epigenetic modification, which has emerged as a potential mechanism by which the father’s weight at conception may influence the future health of his offspring [9, 10, 1719]. Indeed, a growing body of preclinical animal data has suggested that paternal obesity alters the sperm epigenome, which transmits these epigenetic changes to the progeny, in whom metabolism is then altered [2023]. Similarly, in humans, the sperm epigenome of obese men shows an altered DNA methylation profile (as compared to that of lean men) that has also been documented in the offspring of these men [2427]. Thus, the POHaD concept highlights the potential importance of considering paternal BMI around the time of conception in relation to offspring outcomes such as birthweight.

Against this background, the current preconception cohort has provided the unique opportunity to prospectively evaluate the associations of maternal and paternal weight measured at a median of 23.3 weeks before pregnancy with subsequent infant birthweight. With this design, we demonstrate that pregravid maternal BMI and paternal BMI are both independently associated with birthweight, but with very different magnitudes of apparent effect (a concept that has been long recognized in the animal husbandry literature, as described in 1938 by Walton and Hammond in showing the dominant maternal effect in the crossbreeding of Shire horses and Shetland ponies [28]). Theoretically, both pregravid maternal weight and pregravid paternal weight could influence infant birthweight through inherited genetic factors, epigenetic effects, or shared environmental factors such as lifestyle practices, diet, and behavior. Notably, these effects could be similarly attributed to either parent. Conversely, the observed dominant effect of pregravid maternal BMI (as compared to paternal) potentially may point to a maternal-specific effect such as the impact of maternal adiposity on the intrauterine environment, though this remains conjecture at this time. It should also be recognized that the comparatively modest association between pregravid paternal BMI and birthweight does not necessarily rule out the possibility of a POHaD effect on offspring weight that may emerge later in childhood.

A key strength of this study is the prospective assessment of a large population of women and men just prior to pregnancy. Accordingly, this study design can provide an unbiased estimate of the independent associations of pregravid maternal and paternal BMI with infant birthweight. Conversely, given its observational nature, this design cannot provide evidence that modification of parental pregravid weight can affect birthweight. Another limitation is that the study population was comprised of a single ethnicity (Chinese) and was generally lean, such that these findings warrant replication in other populations of different ethnicities and body habitus types. However, as described earlier, Liuyang was specifically selected as the setting for this study because features of the local environment (single maternity hospital and premarriage health assessment) made it possible to establish the large cohort of preconception couples that is required for this analysis.

In quantifying the respective effects of maternal and paternal BMI before pregnancy on infant birthweight, the current data highlight the potential importance of maternal pregravid weight status for reducing the risk of fetal overgrowth and LGA delivery. These findings thus support recent calls for a clinical emphasis on optimizing maternal weight before conception [29, 30]. It should also be recognized that, although these data indicate that pregravid paternal BMI has only a modest impact on birthweight, further studies are needed to determine if effects on offspring growth and development may emerge later in childhood, as per the POHaD concept. For example, in the EDEN (Etude des Déterminants pré et postnatals précoces du développement et de la santé de l’ENfant) mother–child cohort, paternal BMI measured in the late second trimester of pregnancy was not associated with neonatal anthropometry at birth but showed subsequent association with infant weight at 3 months of age [31]. Similarly, in a study of 547 pregnancies, paternal BMI at 28 weeks of gestation was not associated with infant birthweight but correlated with offspring BMI at 1 year [32]. Thus, in light of the association between paternal pregravid BMI and infant birthweight observed in the current study, the evolution of this relationship over time with changes in offspring anthropometry during childhood warrants evaluation in future studies.

In conclusion, this preconception cohort study shows that infant birthweight increased by 42.2 g per unit increase in maternal pregravid BMI but by only a 10.7 g per unit increase in paternal pregravid BMI. While maternal pregravid BMI explained 6.2% of the variance in birthweight, paternal pregravid BMI explained only 0.7%. Furthermore, only maternal BMI before pregnancy was a significant independent predictor of LGA. It thus emerges that, while the prepregnancy BMI of each parent is independently associated with infant birthweight, the dominant influence is maternal weight, thereby supporting current calls for clinical focus on optimizing maternal weight status prior to pregnancy.

Supplementary information

Online Figure (6.3KB, pdf)

Acknowledgements

R.R. holds the Boehringer Ingelheim Chair in Beta-cell Preservation, Function and Regeneration at Mount Sinai Hospital and his research program is supported by the Sun Life Financial Program to Prevent Diabetes in Women. R.R. had full access to the data in the study and final responsibility for the decision to submit for publication. This study was supported by operating grants from the Canadian Institutes of Health Research (CIHR)(MOP 115183 and MOP 86562) and the Natural Science Foundation of China (30872167).

Author contributions

Concept and design: R.R., S.W.W., H.T., G.N.S., M.C.W. Acquisition, analysis, interpretation of data: All authors. Statistical analysis: C.Y. Drafting of the manuscript: R.R. Critical revision of the manuscript for important intellectual content: All authors. Funding and supervision: R.R.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

The online version contains supplementary material available at 10.1038/s41387-021-00172-1.

References

  • 1.Committee on Practice Bulletins—Obstetrics. Macrosomia: ACOG practice bulletin, number 216. Obstet Gynecol. 2020;135:e18–35. doi: 10.1097/AOG.0000000000003606. [DOI] [PubMed] [Google Scholar]
  • 2.Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359:61–73. doi: 10.1056/NEJMra0708473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Skilton MR, Siitonen N, Würtz P, Viikari JS, Juonala M, Seppälä I, et al. High birth weight is associated with obesity and increased carotid wall thickness in young adults: the cardiovascular risk in young Finns study. Arterioscler Thromb Vasc Biol. 2014;34:1064–8. doi: 10.1161/ATVBAHA.113.302934. [DOI] [PubMed] [Google Scholar]
  • 4.McDermott MM, Brubaker L. Prepregnancy body mass index, weight gain during pregnancy, and health outcomes. JAMA. 2019;321:1715. doi: 10.1001/jama.2019.3821. [DOI] [PubMed] [Google Scholar]
  • 5.LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group. Voerman E, Santos S, Inskip H, Amiano P, Barros H, Charles MA, et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA. 2019;321:1702–15. doi: 10.1001/jama.2019.3820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA. 2017;317:2207–25. doi: 10.1001/jama.2017.3635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bellavia A, Mitro SD, Hauser R, James-Todd T. Paternal bias: the impact of not accounting for paternal confounders in reproductive epidemiological studies. Am J Obstet Gynecol. 2020;222:87–8. doi: 10.1016/j.ajog.2019.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Oldereid NB, Wennerholm UB, Pinborg A, Loft A, Laivuori H, Petzold M, et al. The effect of paternal factors on perinatal and paediatric outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2018;24:320–89. doi: 10.1093/humupd/dmy005. [DOI] [PubMed] [Google Scholar]
  • 9.Sharp GC, Lawlor DA. Paternal impact on the life course of obesity and type 2 diabetes in the offspring. Diabetologia. 2019;62:1802–10. doi: 10.1007/s00125-019-4919-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Soubry A. POHaD: why we should study future fathers. Environ Epigenet. 2018;4:dvy007. doi: 10.1093/eep/dvy007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, et al. Association of timing of weight gain in pregnancy with infant birth weight. JAMA Pediatr. 2018;172:136–42. doi: 10.1001/jamapediatrics.2017.4016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, et al. Maternal pre-gravid cardiometabolic health and infant birthweight: a prospective pre-conception cohort study. Nutr Metab Cardiovasc Dis. 2017;27:723–30. doi: 10.1016/j.numecd.2017.05.005. [DOI] [PubMed] [Google Scholar]
  • 13.Dai L, Deng C, Li Y, Zhu J, Mu Y, Deng Y, et al. Birth weight reference percentiles for Chinese. PLoS ONE. 2014;9:e104779. doi: 10.1371/journal.pone.0104779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gilmore LA, Redman LM. Weight gain in pregnancy and application of the 2009 IOM guidelines: toward a uniform approach. Obesity. 2015;23:507–11. doi: 10.1002/oby.20951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Durmuş B, Arends LR, Ay L, Hokken-Koelega AC, Raat H, Hofman A, et al. Parental anthropometrics, early growth and the risk of overweight in pre-school children: the generation R study. Pediatr Obes. 2013;8:339–50. doi: 10.1111/j.2047-6310.2012.00114.x. [DOI] [PubMed] [Google Scholar]
  • 16.Linabery AM, Nahhas RW, Johnson W, Choh AC, Towne B, Odegaard AO, et al. Stronger influence of maternal than paternal obesity on infant and early childhood body mass index: the Fels longitudinal study. Pediatr Obes. 2013;8:159–69. doi: 10.1111/j.2047-6310.2012.00100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Houfflyn S, Matthys C, Soubry A. Male obesity: epigenetic origin and effects in sperm and offspring. Curr Mol Biol Rep. 2017;3:288–96. doi: 10.1007/s40610-017-0083-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ornellas F, Carapeto PV, Mandarim-de-Lacerda CA, Aguila MB. Obese fathers lead to an altered metabolism and obesity in their children in adulthood: review of experimental and human studies. J Pediatr. 2017;93:551–9. doi: 10.1016/j.jped.2017.02.004. [DOI] [PubMed] [Google Scholar]
  • 19.Portha B, Grandjean V, Movassat J. Mother or father: who is in the front line? Mechanisms underlying the non-genomic transmission of obesity/diabetes via the maternal or the paternal line. Nutrients. 2019;11:E233. doi: 10.3390/nu11020233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature. 2010;467:963–6. doi: 10.1038/nature09491. [DOI] [PubMed] [Google Scholar]
  • 21.Ng SF, Lin RC, Maloney CA, Youngson NA, Owens JA, Morris MJ. Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring. FASEB J. 2014;28:1830–41. doi: 10.1096/fj.13-244046. [DOI] [PubMed] [Google Scholar]
  • 22.Wei Y, Yang CR, Wei YP, Zhao ZA, Hou Y, Schatten H, et al. Paternally induced transgenerational inheritance of susceptibility to diabetes in mammals. Proc Natl Acad Sci USA. 2014;111:1873–8. doi: 10.1073/pnas.1321195111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.de Castro Barbosa T, Ingerslev LR, Alm PS, Versteyhe S, Massart J, Rasmussen M, et al. High-fat diet reprograms the epigenome of rat spermatozoa and transgenerationally affects metabolism of the offspring. Mol Metab. 2016;5:184–97. doi: 10.1016/j.molmet.2015.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Soubry A, Guo L, Huang Z, Hoyo C, Romanus S, Price T, et al. Obesity-related DNA methylation at imprinted genes in human sperm: results from the TIEGER study. Clin Epigenetics. 2016;8:51. doi: 10.1186/s13148-016-0217-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Donkin I, Versteyhe S, Ingerslev LR, Qian K, Mechta M, Nordkap L, et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 2016;23:369–78. doi: 10.1016/j.cmet.2015.11.004. [DOI] [PubMed] [Google Scholar]
  • 26.Soubry A, Schildkraut JM, Murtha A, Wang F, Huang Z, Bernal A, et al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med. 2013;11:29. doi: 10.1186/1741-7015-11-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Soubry A, Murphy SK, Wang F. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int J Obes. 2015;39:650–7. doi: 10.1038/ijo.2013.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Walton A, Hammond J. The maternal effects on growth and conformation in Shire horse-Shetland pony crosses. Proc R Soc Lond Ser B, Biol Sci. 1938;840:311–35. [Google Scholar]
  • 29.Mullins E, Murphy O, Davies SC. Pre-conception public health to address maternal obesity. BJOG. 2016;123:159–60. doi: 10.1111/1471-0528.13843. [DOI] [PubMed] [Google Scholar]
  • 30.Zylke JW, DeAngelis CD. Health promotion and disease prevention in children: it’s never too early. JAMA. 2009;301:2270–1. doi: 10.1001/jama.2009.804. [DOI] [PubMed] [Google Scholar]
  • 31.Regnault N, Botton J, Forhan A, Hankard R, Thiebaugeorges O, Hillier TA, et al. Determinants of early ponderal and statural growth in fullterm infants in the EDEN mother-child cohort study. Am J Clin Nutr. 2010;92:594–602. doi: 10.3945/ajcn.2010.29292. [DOI] [PubMed] [Google Scholar]
  • 32.Knight B, Shields BM, Hill A, Powell RJ, Wright D, Hattersley AT. The impact of maternal glycemia and obesity on early postnatal growth in a nondiabetic Caucasian population. Diabetes Care. 2007;30:777–83. doi: 10.2337/dc06-1849. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Online Figure (6.3KB, pdf)

Articles from Nutrition & Diabetes are provided here courtesy of Nature Publishing Group

RESOURCES